**Core tip:** We performed a systematic review and meta-analysis comparing the diagnostic accuracy of video capsule endoscopy and double-balloon enteroscopy (DBE) in cases of obscure gastrointestinal bleeding of vascular origin. This is the first systematic review in this setting. We observed that the diagnostic accuracy of detecting small bowel bleeding from a vascular source is increased with the use of an isolated video capsule endoscope compared with isolated DBE. However, concomitant use increases the detection rate of the bleeding source.

INTRODUCTION
============

Approximately 5% of gastrointestinal bleeding occurs between the ligament of Treitz and the ileocecal valve\[[@B1]-[@B3]\] and can be classified as occult when there is no overt bleeding or overt bleeding with melena or hematochezia. Obscure gastrointestinal bleeding (OGIB) includes both definitions\[[@B1],[@B2],[@B4]\].

The most common sources of OGIB in older patients are small bowel angioectasias (30% to 40%), whereas tumors (17%) are more frequent in patients under 50 years old\[[@B5],[@B6]\]. Other causes include Meckel's diverticula, radiation enteropathy, Dieulafoy's lesions, small-bowel varices, nonsteroidal anti-inflammatory drug enteropathy and inflammatory bowel disease\[[@B7]-[@B10]\].

Although prior evaluation of proximal and distal parts of small bowel with upper and lower endoscopy is recommended, it is occasionally not possible to identify the bleeding source with these methods. In these cases, newer endoscopic evaluation techniques are recommended, such as video capsule endoscope (VCE) and deep enteroscopy \[which encompasses spiral, single, and double-balloon enteroscopy (DBE)\].

The advent of VCE in 1998 enabled direct and painless visualization of small-bowel mucosa\[[@B4],[@B11]\]. DBE, which has been on the market since 2003, allows for the endoscopic scrutiny of the entire small intestine, but it has the disadvantage of being an invasive procedure.

The diagnostic and therapeutic yield of these technologies has been compared with conventional approaches of push enteroscopy (PE), intraoperative enteroscopy and radiologic methods, revealing greater diagnostic yield\[[@B12]\]. Few studies comparing the diagnostic success of VCE and DBE are inconclusive in determining which of these two methods is superior. Thus, we decided to compare these methods in this review.

Although numerous meta-analyses have compared the efficacy of VCE and DBE in detecting an OGIB, this is the first systematic review and meta-analysis comparing OGIBs specifically in vascular origins. The objective of this study is to compare the diagnostic accuracy of VCE and DBE in cases of OGIB of vascular origin.

MATERIALS AND METHODS
=====================

Protocols and registration
--------------------------

This systematic review was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) recommendations and registered on PROSPERO international database ([www.crd.york.ac.uk/prospero/](www.crd.york.ac.uk/prospero/)) under number CRD42017078046.

Eligibility criteria
--------------------

Types of studies: transversal studies from which it was possible to extract information necessary to calculate using only directly or indirectly supplied data. No abstracts or data from unpublished research were accepted. There were no restrictions in terms of language or date of publication.

Types of participants: patients with overt or occult OGIB from a vascular source. There were no restrictions regarding sex, age, risk factors, or anemia level in the study participants.

Types of interventions: VCE and DBE. Only studies that completed both exams, *i.e*., VCE followed by DBE, were included regardless of where the procedure was performed, the type of colon cleaning, and the brand of the capsule or enteroscope.

Outcome measures: the main outcomes were sensitivity, specificity, pretest and posttest probabilities, positive and negative predictive values, and the accuracy of DBE.

Information sources
-------------------

To identify articles, searches were conducted using MEDLINE (*via* PubMed), LILACS (*via* BVS) and Cochrane/CENTRAL virtual databases. Databases were searched from March 2017 to April 2018 with no restriction regard the idiom or the year of publication.

Search
------

The search used varied strategies depending on the database, and these strategies are specified below: (A) PubMed/MEDLINE: (angiodysplasias OR arteriovenous OR malformation OR hemorrhage OR gastrointestinal OR hemorrhages OR hematochezia OR angioectasia OR intestines OR small bowel bleeding OR intestine OR duodenum OR duodenal OR jejunum OR jejunal OR ileum OR ileal OR bleeding OR intestinal OR occult OR obscure phlebectasias) AND (double balloon OR enteroscopy OR enteroscopes OR enteroscopies OR double balloon endoscopy OR capsule endoscopy OR capsule endoscope OR full enteroscopy OR deep enteroscopy) AND (diagnosis/broad\[filter\]); and (B) LILACS and Cochrane/CENTRAL: enteroscopy AND capsule endoscopy AND obscure bleeding.

Study selection
---------------

Articles were initially selected after an assessment of the titles and abstracts to assess the relevance of the full text. Then, abstracts were read, and those that did not fit the inclusion criteria were excluded. Two independent reviewers performed eligibility assessment and study selection. Disagreements between reviewers were resolved by consensus.

Data collection process
-----------------------

The method of data extraction from each included study consisted of completing information sheets after the paper was read. Relevant data were then extracted from each included study using a standardized extraction form. One review author extracted data from the included studies, and a second author checked the extracted data. Disagreements were resolved by discussion between the two review authors.

Data items
----------

The selected data included age, gender, total number of patients, study design, VCE and DBE models, intestinal preparation, interval time between VCE and DBE, number of patients with diagnoses of small-bowel bleeding using VCE and DBE and number of vascular lesions found. Only bleeding from vascular lesions was considered true positive diagnostically. We classified "vascular lesions" as angiodysplasias, varices, hemangiomas, red spots, and Dieulafoy lesions. Bleeding from tumor, ulcer, erosions, polyps and masses were not classified as vascular lesions but were considered bleeding from alternative sources.

Risk of bias in individual studies
----------------------------------

To evaluate the risk of bias and the applicability of primary diagnostic accuracy studies, we used the QUADAS-2 tool (Table [1](#T1){ref-type="table"}), which is structured in four domains. The first domain is patient selection, which we described in terms of risk of bias. The second domain is a description of the index test, including analysis of how it was conducted and interpreted. The third domain is the reference standard, namely its description, conduction and interpretation. The fourth domain is flow and timing, where we recorded any patient who did not receive the index test(s) and/or reference standard, patients who were excluded from the analysis, and the time interval or any interventions that occurred between the index test(s) and the reference standard.

###### 

QUADAS-2. Risk of bias in individual studies

  **Study**                                                                                                                   **Hadithi et al, 2006\[[@B4]\]**   **Hermans et al, 2017\[[@B11]\]**   **Holleran et al, 2014\[[@B37]\]**   **Kaffes et al, 2007\[[@B34]\]**   **Kalra et al, 2015\[[@B16]\]**   **Kamalapor et al, 2008\[[@B30]\]**   **Kameda et al, 2008\[[@B27]\]**   **Li et al, 2010\[[@B35]\]**   **Lin et al, 2007\[[@B40]\]**   **Maeda et al, 2015\[[@B32]\]**   **Marmo et al, 2009\[[@B23]\]**   **TianMin, et al, 2013\[[@B39]\]**   **Nakamura et al, 2006\[[@B29]\]**   **Rahmi et al, 2013\[[@B33]\]**   **Chu et al, 2016\[[@B17]\]**   **Zhang, et al, 2015\[[@B15]\]**
  --------------------------------------------------------------------------------------------------------------------------- ---------------------------------- ----------------------------------- ------------------------------------ ---------------------------------- --------------------------------- ------------------------------------- ---------------------------------- ------------------------------ ------------------------------- --------------------------------- --------------------------------- ------------------------------------ ------------------------------------ --------------------------------- ------------------------------- ----------------------------------
  Was a consecutive or random sample of patients enrolled?                                                                    YES                                UNCLEAR                             UNCLEAR                              YES                                UNCLEAR                           UNCLEAR                               YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  YES                               YES                             UNCLEAR
  Was a case-control design avoided?                                                                                          YES                                YES                                 NO                                   YES                                YES                               NO                                    YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  YES                               YES                             YES
  Did the study avoid inappropriate exclusions?                                                                               YES                                YES                                 YES                                  YES                                UNCLEAR                           NO                                    YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  YES                               YES                             NO
  Could the selection of patients have introduced bias?                                                                       LOW                                MODERATE                            HIGHT                                LOW                                HIGH                              HIGH                                  LOW                                LOW                            LOW                             LOW                               LOW                               LOW                                  LOW                                  LOW                               LOW                             HIGH
  Are there concerns that the included patients do not match the review question?                                             LOW                                LOW                                 LOW                                  LOW                                LOW                               LOW                                   LOW                                LOW                            LOW                             LOW                               LOW                               LOW                                  LOW                                  LOW                               LOW                             HIGH
  Were the index test results interpreted without knowledge of the results of the reference standard?                         YES                                NO                                  YES                                  NO                                 YES                               NO                                    YES                                UNCLEAR                        UNCLEAR                         UNCLEAR                           YES                               NO                                   YES                                  NO                                NO                              UNCLEAR
  If a threshold was used, was it prespecified? Could the conduct or interpretation of the index test have introduced bias?   YES LOW                            YES MODERATE                        YES LOW                              YES MODERATE                       NO MODERATE                       YES MODERATE                          YES LOW                            YES MODERATE                   NO MODERATE                     YES MODERATE                      YES LOW                           NO HIGH                              YES LOW                              YES MODERATE                      YES MODERATE                    YES MODERATE
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Are there concerns that the index test, its conduct, or interpretation differ from the review question?                     LOW                                LOW                                 LOW                                  LOW                                LOW                               LOW                                   LOW                                LOW                            LOW                             LOW                               LOW                               LOW                                  LOW                                  LOW                               LOW                             HIGH
  Is the reference standard likely to correctly classify the target condition?                                                YES                                YES                                 YES                                  YES                                YES                               YES                                   YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  YES                               NO                              UNCLEAR
  Were the reference standard results interpreted without knowledge of the results of the index test?                         YES                                NO                                  YES                                  NO                                 YES                               YES                                   YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  YES                               YES                             UNCLEAR
  Could the reference standard, its conduct, or its interpretation have introduced bias?                                      LOW                                MODERATE                            LOW                                  MODERATE                           LOW                               LOW                                   LOW                                LOW                            LOW                             LOW                               LOW                               LOW                                  LOW                                  LOW                               HIGH                            HIGH
  Are there concerns that the target condition as defined by the reference standard does not match the review question?       LOW                                LOW                                 LOW                                  LOW                                LOW                               LOW                                   LOW                                LOW                            LOW                             LOW                               LOW                               LOW                                  LOW                                  LOW                               HIGH                            HIGH
  Was there an appropriate interval between index test(s) and reference standard?                                             YES                                NO                                  NO                                   NO                                 NO                                NO                                    YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  NO                                YES                             UNCLEAR
  Did all patients receive a reference standard?                                                                              YES                                YES                                 YES                                  YES                                YES                               YES                                   YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  YES                               YES                             YES
  Did all patients receive the same reference standard?                                                                       NO                                 YES                                 YES                                  YES                                YES                               YES                                   YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  YES                               YES                             YES
  Were all patients included in the analysis?                                                                                 YES                                YES                                 YES                                  YES                                YES                               YES                                   YES                                YES                            YES                             YES                               YES                               YES                                  YES                                  YES                               YES                             YES
  Could the patient flow have introduced bias?                                                                                MODERATE                           LOW                                 LOW                                  LOW                                LOW                               MODERATE                              LOW                                LOW                            LOW                             LOW                               LOW                               LOW                                  LOW                                  MODERATE                          LOW                             LOW

Summary measures
----------------

The sensitivity, specificity, pretest probability, positive and negative predictive values, and accuracy of DBE were the primary outcome measures and calculated using data provided from the original papers. Analysis was performed using capsule endoscopy as the gold standard for detection of small bowel lesions. We also created a summary receiver operating characteristic curve (sROC). All of these variables were subjected to per-lesion analyses. I-square was used to evaluate heterogeneity. Studies that remained under 50% of the sROC curve were removed.

Data were organized, and averages and standard deviations were calculated using Microsoft Excel Software 2013. Analysis was performed using the Meta-Disc 1.4 software.

RESULTS
=======

In the per-patient analysis, 17 studies (1477 lesions) were included (Figure [1](#F1){ref-type="fig"}). In 3150 exams (1722 VCE and 1428 DBE) performed in 2043 patients, 2248 sources of bleeding were identified, of which 1467 were found to be vascular lesions and 781 were related to other sources, including tumor, ulcer, erosions, polyps and mass. Eight hundred and sixty-four (58.5%) lesions were diagnosed by VCE, and 613 (41.5%) by DBE. Of these, 605 (40.9%) were angiodysplasia; 5 (0.33%) were varices; 160 (10.8%) were described as blood and clots/bleeding, active bleeding or bleeding; 11 (0.74%) were red spots; 45 (3.04%) were described as arteriovenous malformation; 10 (0.67%) Dieulafoy lesions; 7 (0.47%) angiomas; and 74 (5.01%) were described generically as vascular lesions. Some patients were subjected to the same exam twice, and some of the sources of bleeding were identified by both exams.

![Flow diagrams - PRISMA\[[@B36]\].](WJGE-10-400-g001){#F1}

The sensitivity of DBE was 84% \[95% confidence interval (CI): 0.82-0.86; heterogeneity: 78.00%\] (Figure [2](#F2){ref-type="fig"}), and the specificity was 92% (95%CI: 0.89-0.94; heterogeneity: 92.0%) (Figure [3](#F3){ref-type="fig"}). The positive likelihood ratio was 11.29 (95%CI: 4.83-26.40; heterogeneity: 91.6%) (Figure [4](#F4){ref-type="fig"}), and the negative likelihood ratio was 0.20 (95%CI: 0.15-0.27; heterogeneity: 67.3%) (Figure [5](#F5){ref-type="fig"}).

![Forrest plot: Double-balloon enteroscopy sensitivity per-lesion analysis.](WJGE-10-400-g002){#F2}

![Forrest plot: Double-balloon enteroscopy specificity per-patient analysis.](WJGE-10-400-g003){#F3}

![Forrest plot: Double-balloon enteroscopy positive likelihood ratio per-patient analysis.](WJGE-10-400-g004){#F4}

![Forrest plot: Double-balloon enteroscopy negative likelihood ratio per-patient analysis.](WJGE-10-400-g005){#F5}

The posttest probability was 41.6% for DBE in the studied population and 85% for VCE. The area under the sROC curve was 0.9469 for DBE (Figure [6](#F6){ref-type="fig"}) and 0.9526 for VCE (Figure [7](#F7){ref-type="fig"}). The difference between the areas under independent ROC curves was 0.006, and the *P*-value was 0.41 (two-tailed).

![Summary receivers operating characteristic curve for double-balloon enteroscopy in per-patient analysis. sROC: Summary receiver operating characteristic.](WJGE-10-400-g006){#F6}

![Summary receiver operating characteristic curve for video capsule endoscopy in per-patient analysis. sROC: Summary receiver operating characteristic.](WJGE-10-400-g007){#F7}

Performing DBE after CE increased the diagnostic yield to vascular lesion by 7% from 83% to 90%

STUDY CHARACTERISTICS
=====================

Information extracted from each paper included characteristics of trial participants (including age, gender), study design, VCE and DBE models, intestinal preparation, interval time between VCE and DBE, number of patients with diagnoses of small-bowel bleeding using VCE and DBE, number of vascular lesions found, and the source of obscure gastrointestinal bleeding (Table [2](#T2){ref-type="table"}).

###### 

Studies characteristics

                                     **Median age; range**   **Patient total**   **Study design**                     **VCE Model**                                                                                      **DBE Model**                                                                       **Preparation**                                                                                                                                                                                                                                         **Interval CE × DBE**   **No. of patients with diagnoses of SBB by CE/total CE performed**        **No. of patients with diagnoses of SBB by DBE/total DBE performed**
  ---------------------------------- ----------------------- ------------------- ------------------------------------ -------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ------------------------------------------------------------------------- ----------------------------------------------------------------------
  Fujimoto et al\[[@B28]\], 2007     64 (38-93)              45 M: 25 F: 20      Prospective study                    Pillcam (Given Imaging, Yoqneam, Israel).                                                          EN-450P5 DBE diagnostic model and/or the EN-450T5                                   CE: 12 h fast + 1 L sodium sulfate/sodium bicarbonate DBE: 72 h after CE in 36 pct                                                                                                                                                                      72 h                    18/45 Angiodysplasia: 6 Varices: 2 jejunal                                18/36
  Hadithi et al\[[@B4]\], 2006       63.2 (19-86)            35 M:22 F: 13       Prospective blinded study            Given M2A, Given Imaging Ltd., Yoqneam, Israel                                                     Fuji Photo Optical Incorporated Company Fujinon Inc., Japan                         CE: fast overnight after the ingestion of 1 L of sodium sulfate/sodium bicarbonate solution DBE: fast overnight after ingestion of 1 L clean prep. for the antegrade approach and bowel cleansing as for colonoscopy (4 L Klean prep)                   7 to 14 d               21/35 AVM: 19 Fresh blood and clots: 5                                    28/35 AVM: 16 Fresh blood and clots: 2
  Hermans et al\[[@B11]\], 2017      69 (18-91)              146 M: 91 F: 55     Retrospective observational study.   Olympus VC (Olympus EndoCapsule; Tokyo, Japan) and Pillcam VC (Covidien plc, Dublin, Ireland)      Fujinon Double-Balloon Enteroscopy System (Fujinon GMBH, Germany), EN-450T5         CE: 2 L PEG in a single or split dose DBE: 1 L PEG divided into two doses to be used twice                                                                                                                                                              111 (1--1091) days      105/134 Angiodysplasias: 70 active bleedings without visible focus : 35   93/146 Angiodysplasias: 19
  Holleran et al\[[@B37]\], 2013     54 (16-90)              246 M: 130 F: 116   Retrospective comparative study      SB1 or SB2 pillcam (Given imaging, Yokneam, Israel)                                                Fujinon double-balloon enteroscope (EN-450P5/20, Fujinon, Inc., Saitama, Japan)     CE: No preparation was required other than an overnight fast. Anterograde DBE: overnight fast Retrograde DBE: PEG the day prior                                                                                                                         NR\*                    40/46 Angiodysplasia: 10 Active bleeding: 3                               116/246 Angiodysplasias: 44
  Kaffes et al\[[@B34]\], 2007       62 ± 18                 60                  Prospective cohort study             M2A; Given Imaging Ltd, Yoqneam, Israel)                                                           Fujinon                                                                             CE, DBE: fasting period of 8 h before the oral procedure and a bowel preparation with a sodium (Picoprep; Pharmatel, Thornleigh, Australia)                                                                                                             NR\*                    45/60 Angiectasia:28 Red spots: 9 Blood: 8                                45/60 Angioectasia: 21 Red spots: 9 Blood: 8
  Kalra, A et al\[[@B16]\], 2015     66.6 ± 13.2             116 M:65 F: 51      Retrospective review                 Medtronic, Duluth, GA, the United States                                                           Fujifilm Medical System, Stanford, CT, the United States                            Retrograde DBE: bowel preparation the night before the procedure.                                                                                                                                                                                       1 yr                    /69                                                                       29/69 AVM: 29
  Kamalaporn et al\[[@B30]\], 2008   64.1 (34-83)            195 M: 26 F:25      Retrospective review                 Given M2A CE system (Given Imaging Ltd, Israel)                                                    Fujinon DBE system (Fuji Photo Optical Incorporated Company, Fujinon Inc., Japan)   CE: 2 to 4 L PEG and fasted overnight, at least 8 h before the procedure DBE: 4 L PEG and fasted overnight                                                                                                                                              139 (40 to 335) d       181/202 studies Angiodysplasia: 33 Bleeding: 22                           56/56 Angiodysplasia: 36 Bleeding: 9
  Kameda et al\[[@B27]\], 2008       62.4 (27-84)            32 M: 13 F: 19      Prospective single-blind trial       Pill Cam capsule (M2A, Given Imaging, Yoqneam, Israel)                                             DBE system (FujinonToshiba ES System, Saitama, Japan)                               CE: fasting after midnight on the evening before the examination (minimum 8 h) DBE: overnight fasting and ingestion of 1 l of electrolyte lavage preparation (Niflec, Ajinomoto Pharma, Tokyo, Japan) in the morning.                                   1-7 d                   29/32 Angiodysplasia: 8 bleeding: 6                                       21/32 Angiodysplasia: 7 bleeding: 6
  Li et al\[[@B35]\], 2010                                   190                 Prospective study                    M2A, Given Imaging, Ltd. (Yoqneam, Israel)                                                         Fujinon EN-450P5/ 20 and EN-450P5/28 (Fujinon Inc., Saitama, Japan)                 CE: 1 L of PEG electrolyte 12 h before the procedure Anterograde DBE: fasted for 8 h. Retrograde DBE: PEG electrolytes preparation 4 h before the examination                                                                                           5.8 d (1-18)            165/190 AVM: 7 Fresh blood or clots: 8                                    34/51 AVM: 9 Bleeding: 0 Angioma: 4
  Lin et al\[[@B40]\], 2007          63.5 ± 22.7 (11-87)     10 M:3 F:7          Prospective study                    Pill Cam SB capsule (Given Imaging, Yoqneam, Israel)                                               DBE: EN- 450P5 and the EN-450T5                                                     CE: fast overnight for 8-12 h Anterograde DBE: fasting for 6-8 h Retrograde DBE: bowel cleansing as in a colonoscopy.                                                                                                                                   7 d                     9/10 Angiodysplasias: 3 Bleeding: 3                                       8/10 Angiodysplasias: 3 Varices: 1 Dieulafoy's lesion: 1
  Maeda et al\[[@B32]\], 2010        70 (30-92)              89 M: 48 F: 41      Retrospective analysis               PilCam SB® (SB1, SB2, or SB3) (Covidien, Irvine, CA, the United States).                           (EN-450 T5/W or EN-580 T, Fujinon Inc., Saitama, Japan)                             NR\*                                                                                                                                                                                                                                                    24 h                    58/89 Angioectasia: 8 AVM : 3 Dieulafoy lesion: 9 Varices: 2              29/37 Angioectasia:8 AVM: 3 Dieulafoy lesion:6 Varice: 1
  Marmo R et al\[[@B23]\], 2008      61.6 ± 16.2             193 M: 119 F: 74    Prospective study                    Pillcam SB                                                                                         Fujinon Double-Balloon Enteroscopy System                                           Anterograde DBE: fasting period of 8 h Retrograde DBE: 4 L PEG-based preparation                                                                                                                                                                        2 wk                    175/193 Vascular lesions: 74 Blood or clot: 34                            132/193 Vascular lesions: 72
  Tian Min et al\[[@B39]\], 2013     55.4 (23-78)            62 M: 34 F:28       Prospective study                    Pill Cam SB capsule                                                                                EN-450P5 and the EN-450T5 (Fujinon)                                                 CE: 2 L to 4 L PEG and fasted overnight Anterograde DBE: fasting for 6-8 h before the procedure. Retrograde DBE: bowel cleansing as in a colonoscopy.                                                                                                   15 (4-60) d             44/62 Angiodysplasia: 26 Bleeding: 26                                     48/62 Angiodysplasia: 27 Bleeding: 30
  Nakamura et al\[[@B29]\], 2006     58.5 (25 ± 85)          32 M: 21 F: 11      Prospective and blinded              M2A, Given Imaging,                                                                                Fuji EN−450 T5/20                                                                   CE: fluid diet for 12 h and observed a fasting period starting at midnight Anterograde DBE: fasted for 12 h Retrograde DBE: clear liquid diet on the day before the examination and PEG electrolyte lavage solution on the morning of the examination   48 h                    19/32 Angiodysplasias: 4 Red spots: 2                                     12/28 Angiodysplasias: 2 Red spots: 2
  Rahmi et al\[[@B33]\], 2013        67 ± 11                 383 M: 114 F: 269   Prospective, multicenter study       PillCam SB device                                                                                  EN-450P5 and EN-450T5; Fujinon                                                      CE: residue-free diet 2 d before VCE ingestion; 2 L PEG solution the night before the examination; patients then fasted overnight Anterograde DBE: No bowel preparation Retrograde DBE: 4 L of a PEG solution was given the day before the procedure    4.1 ± 6.3 mo            266/383 Angiodysplasia: 266                                               205/266 Angiodysplasia: 190
  Chu et al\[[@B17]\], 2016          51.1 ± 17.1             121 M: 60 F: 61     Study Cohorts                        OMOM capsule endoscopic device (Jinshan Science and Technology Group Co., Ltd, Chongqing, China)   Fujinon EN-450P5/20                                                                 CE: 2 L polyethylene glycol-based electrolyte solution 12 h prior to the test, followed by an overnight fast for bowel preparation fast Retrograde DBE: bowel preparation used for CE procedure the day before the examination                          1 wk                    115/121 Angiodysplasia: 86% Active bleeding: 6                            29/46 Angiodysplasia: 9
  Zhang et al\[[@B15]\], 2015        47.19 (16-78)           88 M: 64 F: 24      Prospective study                    Pill Cam SB                                                                                        Fuji DBE system                                                                     CE: 3 liters of PEG (2 liters at 10:00 pm the night before the procedure, and 1 L with the simethicone at 4:00 am on the morning of the procedure) Anterograde DBE: fast for 6-8 h Retrograde DBE: 2 L of PEG                                           NR                      53/88 MAV: 14 Hemangioma: 0 Diverticulum with a Bleeding: 1               52/88 MAV: 10 Hemangioma: 3 Diverticulum with a Bleeding: 7

M: Male; F: Female; SBB: Small bowel bleeding; PEG: Polyethylene glycol solution; AVM: Arteriovenous malformation; VC: Video capsule; NR: Not related; DBE: Double-balloon enteroscopy; VCE: Video capsule endoscope.

All studies had similar characteristics; they studied the use of VCE and DBE in the diagnoses of OGIB sources, listing the sources separately. None of the studies classified vascular lesions according to the Yano\[[@B13]\] or Saurin\[[@B14]\] classification for vascular lesions of the small bowel.

A retrograde and/or anterograde route was decided based on VCE findings. Full enteroscopy using DBE was not always performed. The interval time was different in all studies based on institutional protocols. There were different definitions for vascular lesions. Every study reported a positive predictive value greater than 90%, except Fujimori\[[@B2]\] (33.33%) and Zhang\[[@B15]\] (53.31%).

Fujimori\[[@B2]\] exhibited high heterogeneity in poll specificity and sensitivity in addition to a poll accuracy under the medium media on SROC curve. Therefore, we excluded this paper.

Risk of bias within studies
---------------------------

Most studies (thirteen) had a low risk of bias. In 3 studies, DBE was performed after VCE, which could introduce bias in the route used (antegrade/retrograde). QUADAS-2 revealed that most studies did not exhibit bias. All studies followed the same pattern of inclusion: positive findings for VCE with posterior use of DBE performed in the same center.

Kalra\[[@B16]\] used Medtronic, Duluth, and the United States VCE, whereas Chu\[[@B17]\] used the OMOM capsule endoscopic device. All other studies were performed using the given imaging device.

Complementary analysis
----------------------

Analyzing DBE as the standard procedure resulted in the following metrics for VCE: sensitivity of 93% (95%CI: 0.91-0.95; heterogeneity: 89.0%); specificity of 82% (95%CI: 0.79-0.84; heterogeneity: 87.3%); positive likelihood ratio of 5.44 (95%CI: 3.22-9.21; heterogeneity: 88.0%); negative likelihood ratio of 0.07 (95%CI: 0.03-0.18; heterogeneity: 91.3%) and accuracy of 86.75%.

DISCUSSION
==========

VCE and DBE were developed as new examination techniques for the small intestine and have the potential to overcome conventional enteroscopy\[[@B11]\]. The small bowel is difficult to inspect with endoscopic methods. Prior to evaluation of the small bowel, it is recommended to repeat an upper digestive endoscopy and a colonoscopy\[[@B18]\]. Although intraoperative enteroscopy is the best for observing the entire small bowel, it is the most invasive procedure.

This is the first systematic review with meta-analysis to analyze the accuracy of DBE combined with VCE in diagnosing vascular lesions as a source of small bowel bleeding. The studies selected exhibited homogeneous intervention in a large number of patients. Eligibility criteria were strict, and selection and analysis were performed using international recognized protocols to avoid bias.

Saurin et al\[[@B14]\] divided the small bowel lesions into three distinct groups: submucosal veins, diverticula and nodules are included in the P0 lesions group; red spots and small or isolated erosions are considered P1 lesions; and angioectasias, varices, ulcerations and tumors represent P2 lesions. Yano et al\[[@B13]\] divided vascular small bowel lesions into 4 types depending on their characteristics and the presence or absence of bleeding. None of the studies in this meta-analysis divided the vascular lesions according to these classifications. Many sources of obscure bleeding were of vascular origin. When an endoscopic capsule or enteroscopy examination is performed and a source of bleeding is not identified, the cause is considered to be vascular by default. Thus, flash blood and clots/bleeding, active bleeding, and bleeding were considered as vascular sources in our study.

The benefits of VCE include the noninvasive nature of the test, patient acceptance, safety and diagnostic yield. However, it is limited by the inability to perform conventional endoscopic procedures, such as air insufflation, local reexamination, rinsing, biopsy, therapeutic intervention and precise identification of lesions. However, in DBE, a complete small bowel examination is typically not possible using only one route, so it often requires combined oral and rectal approaches. Diagnostic algorithms to identify gastrointestinal bleeding have suggested that VCE is best used initially to identify the lesion. DBE is best used for performing a therapeutic procedure after VCE. Thus, VCE was chosen as the gold standard in this review.

The diagnostic yield of VCE, DBE and single balloon enteroscopy (SBE) appears highest for patients with ongoing overt bleeding\[[@B19]-[@B21]\]. Comparing VCE and SBE, Shiani et al\[[@B19]\] reported a strong degree of concordance between VCE and SBE for active bleeding and clots but only moderate concordance for vascular lesions and fair concordance for ulcers. The diagnostic yield of VCE is increased if performed within 2 wk (greatest in 48 to 72 h). The timing of capsule endoscopy can influence the diagnosis and outcomes in patients with small bowel bleeding by identifying patients for early intervention, leading to endoscopic or surgical interventions or changes in medical management\[[@B22]\]. A study reported a high diagnostic and therapeutic yield (90%) with early (within 24 h) DBE in 10 patients with overt small bowel bleeding\[[@B23]\].

Regarding emergency ongoing overt OGIB, European Society of Gastrointestinal Endoscopy suggests that small bowel capsule endoscopy or device-assisted enteroscopy should be considered as a first-line approach\[[@B24]\]. Studies included in this meta-analysis did not differentiate the cause of bleeding as emergency or nonemergency. However, our results revealed increased accuracy of VCE to identify the vascular source of bleeding compared with DBE. This result demonstrates the ability of VCE to exclude lesions and to demonstrate the direction of the DBE. These results allow us to recommend the capsule as the first-line approach in these cases.

In the evaluation of OGIB, Martínez et al\[[@B25]\] demonstrated that the overall diagnostic yield of antegrade DBE is roughly equivalent to VCE; however, the diagnostic yield of DBE is increased when pre-DBE imaging is positive. A lesion source is frequently identified when pre-DBE imaging is negative or not performed. In a systematic review with 9 articles, Westerhof et al\[[@B26]\] reported that the diagnostic yields of CE and DBE for OGIB varied between 38% and 83% for CE and between 43% and 75% for DBE. The concordance between findings of CE with those of DBE varied between 29% and 92%, and the most frequent diagnosis was angiodysplasias. Our review reveals that DBE is reasonably sensitive and exhibits high specificity; however, it performs worse than VCE. Performing DBE after the CE increases the vascular lesion detection index by 7% from 83% to 90%.

This study is helpful for selecting the best initial diagnostic procedure in patients in whom vascular bleeding is suspected, such as cases of vascular syndromes, elderly patients and patients using anticoagulants. In many locations, these procedures are associated with high costs and are not always available at the same center. Although suggestions for the use of DBE as the first choice in obscure bleeding are reported, we have demonstrated that VCE would be the best and safest choice based on a 7% increase in diagnostic yield of DBE regardless of the severity of the case.

Variables that have been associated with an increased detection rate includes earlier VCE, inpatient status, overt GI bleeding with transfusion requirement, male sex, increasing age, use of warfarin and liver comorbidity\[[@B24]\]. Unfortunately, the articles did not stratify the findings according to these variables but according to the findings of the examinations, preventing very interesting data from being collected and analyzed.

A greater sensitivity of DBE in small bowel OGIB after using the VCE as the initial examination was observed. Considering the high sensibility of VCE in relation to DBE (93% × 84%), we suggest its use for suspicion of vascular lesions. Despite the low specificity noted when using VCE after DBE, its posttest result is double that of DBE (85% × 41.6%), prompting us to suggest using this feature after DBE with a negative finding. In this meta-analysis, we included studies in which VCE was performed before enteroscopy, and the route was chosen according to the possible location of the finding in the VCE. This procedure leads to an increased probability of finding the lesion with DBE. On the other hand, some enteroscopies were not completed because they only used one of the insertion pathways.

In one study\[[@B27]\] that attempted complete small bowel examination, all patients underwent both an antegrade and retrograde DBE procedure, whereas the DBE strategy varied in the other studies. In two studies, the antegrade or retrograde approach of DBE was chosen based on the VCE findings\[[@B2],[@B28]\]. One study\[[@B29]\] chose the route of DBE based on the medical history. One study\[[@B4]\] chose the antegrade route of DBE in all cases followed by an alternate approach if considered necessary. In many studies, the decision to perform an additional DBE using the alternate route was made after considering several factors, including the results of the initial procedure, clinical indication, and patient consent. Two studies\[[@B29],[@B30]\] had a single-blinded design.

The mean age of our study was 57.2 years. Angiectasias accounts for 20% to 30% of small bowel bleeding and are more commonly observed in older patients. In addition, bleeding in those who use nonsteroidal anti-inflammatory drugs and proper intestinal preparation facilitates lesion identification. The analyzed studies did not stratify the findings in the examinations regarding age, use of medications (nonsteroidal anti-inflammatory drugs), urgency/emergency indications, and bowel preparation, which prevents us from analyzing more data that would provide valuable information\[[@B31]\].

Although studies have assessed the diagnostic yield of VCE, PE, and device-assisted enteroscopy in OGIB, the precise significance of lesions identified and the impact on clinical outcome have not been consistently evaluated for those modalities. In the case of OGIB, a positive patient outcome should be either cessation of bleeding or resolution of anemia. Several studies have demonstrated a change in patient management and improved outcomes following VCE and device-assisted enteroscopy\[[@B32]\].

Of the included manuscripts, seven included patient follow-up. The mean duration of follow-up varied from 5 to 12 mo. Patients continued to exhibit bleeding in most of these studies, ranging from 65% to 81% including those whose findings were external of the small bowel\[[@B4],[@B25],[@B27],[@B31],[@B33]-[@B35]\].

Our study has some limitations, including nonstandardized follow-up of the patients after the exams, no standardized bowel preparation between the studies and no standard interval time between the exams. Additionally, performing DBE after a VCE exam facilitates the decision of the insertion route for enteroscopy (Figure [8](#F8){ref-type="fig"}). All of these limitations appear to favor DBE. The analyzed studies did not stratify the findings in the examinations regarding age, use of medications (nonsteroidal anti-inflammatory drugs), urgency/emergency of the indication, and the preparation, which prevents us from analyzing more data that would provide valuable information. These are data that would enrich the revision; however, they depend on the particularities of conduct of each author.

![Suggested management approach to overt and occult small-bowel bleeding after upper endoscopy and colonoscopy did not identify vascular bleeding origin. Positive test results should direct specific therapy. When video capsule endoscopy is contraindicated or unavailable, device-assisted endoscopy may serve as the initial test for small-bowel evaluation. VCE: Video capsule endoscopy; DAE: Device-assisted endoscopy; DBE: Double-balloon enteroscopy.](WJGE-10-400-g008){#F8}

In conclusion, the diagnostic accuracy of detecting small bowel bleeding from a vascular source is greater with the use of an isolated VCE compared with isolated DBE. However, concomitant use increases the detection rate of the bleeding source.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Obscure gastrointestinal bleeding (OGIB) is a challenge to the professional who faces this occurrence. Although only a small part of these bleeds occurs in the midgut, the difficulty in accessing it implies a longer interval between the onset of symptoms and diagnosis and therapy. Initially, we used enteroscopes with single balloon, including spiral and double balloon overtubes, which is the most commonly used. Subsequently, the endoscopic capsule was introduced, allowing a greater index of complete observation of the small intestine with greater comfort to the patient. A weakness includes the therapeutic impossibility present in balloon enteroscopy. Due to the particularities of each of the methods, we should seek data in the available scientific literature to support our most appropriate diagnostic decision.

Research motivation
-------------------

Video capsule endoscopy (VCE) and double-balloon enteroscopy (DBE) are recognized endoscopic diagnostic approaches for OGIB, for which vascular origins represent the most common source. Our initial motivation was to determine whether there is a preferential diagnostic approach in OGIB by vascular origin that maintains high accuracy. From the literature review about the subject, we realized some characteristics that we interpreted as important limitations in the previous works. Thereafter, this study sought to remove these limitations and to follow a rigorous methodological approach in the selection and analysis to enhance knowledge about accuracy data.

Research objectives
-------------------

We want to compare accuracy data between the two most widespread indicated endoscopic approach methods in OGIB: VCE and DBE. It was possible to obtain a large sample of patients submitted to both methods from the literature. We believe that future systematic reviews on this issue can be based on our selection and analysis methodology. In addition, new studies that will be published can be added to update and provide a greater dimension to the theme.

Research methods
----------------

This systematic review was conducted according to the PRISMA Statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and registered on PROSPERO international database. The search was performed in the electronic databases MedLine (*via* PubMed), LILACS (*via* BVS) and Cochrane/CENTRAL virtual databases. The QUADAS-2 tool was used to evaluate the risk of bias and the applicability of primary diagnostic accuracy studies and the incorporation of recent studies on the OGIB approach. All articles were read and chosen based on common consensus among three authors, and restricted inclusion criteria provide greater magnitude and accuracy.

Research results
----------------

Seventeen studies were included with 3150 exams performed in 2043 patients, resulting in the identification of 1467 vascular lesions. The specificity found for DBE is greater than that of VCE (92% *vs* 82%) possibly because the examiner is able to examine in more detail the alterations found when performing DBE. In contrast, the sensitivity of the VCE is greater than that of the DBE (93% *vs* 84%) perhaps due to the natural increase in the capacity of the lens of the capsule and the fact that the insufflation of air in the small intestine during the examination with DBE greatly increases the pressure in the organ above the capillary pressure, which prevents the lesions from being observed in this exam. The increase in the diagnostic yield to the vascular lesion is greater when the DBE is performed after VCE.

Research conclusions
--------------------

Through direct meta-analysis of the largest sample ever collected, we compared in isolation the diagnostic methods studied. The diagnostic accuracy of detecting small bowel bleeding from a vascular source is greater with VCE despite reduced specificity. This study sought to remove the bias from the lack of methodological rigor applied in the restrict inclusion criteria with the use of more than two authors for study selection and rigorous protocols accepted worldwide for the choice these studies, thus obtaining more purified results. This study also proposes that in addition to contributing to a greater specificity intrinsic to the examination, performing DBE after the use of VCE contributes to increased accuracy.

Research perspectives
---------------------

The comparison between these two methods through meta-analyses always could be inﬂuenced by the technical differences applied in each study. A pertinent study design would include multicentric study with standardized protocols of care, including initial care, standard interval time between onset of symptoms and the first exam, standardized time between the exams, and standardized patient follow-up and bowel preparation.
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